Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Glaukos Corp    GKOS

GLAUKOS CORP (GKOS)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/15/2017 11/16/2017 11/17/2017 11/20/2017 11/21/2017 Date
27.39(c) 27.07(c) 26.45(c) 28.21(c) 25.35(c) Last
1 242 062 1 280 580 903 594 1 684 136 1 355 803 Volume
-4.40% -1.17% -2.29% +6.65% -10.14% Change
More quotes
Financials ($)
Sales 2017 158 M
EBIT 2017 0,61 M
Net income 2017 -1,47 M
Finance 2017 10,0 M
Yield 2017 -
Sales 2018 176 M
EBIT 2018 5,63 M
Net income 2018 3,67 M
Finance 2018 28,0 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 176,29
EV / Sales2017 5,47x
EV / Sales2018 4,81x
Capitalization 876 M
More Financials
Company
Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of products and procedures designed to transform the treatment of glaucoma.Its micro invasive glaucoma surgery procedures are designed to reduce intraocular eye pressure by improving... 
More about the company
Surperformance© ratings of Glaukos Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAUKOS CORP
11/09 GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form..
11/08 GLAUKOS : Management's Discussion and Analysis of Financial Condition and Result..
11/08 GLAUKOS : beats Street 3Q forecasts
11/07 GLAUKOS CORP : Results of Operations and Financial Condition, Change in Director..
11/07 GLAUKOS CORPORATION : Announces Third Quarter 2017 Financial Results
11/07 GLAUKOS CORP : to Host Earnings Call
10/31 GLAUKOS : Announces Participation in Stifel 2017 Healthcare Conference
10/24 GLAUKOS CORPORATION : to Release Third Quarter 2017 Financial Results after Mark..
10/05 GLAUKOS : iStent® Products to be Showcased at 2017 European Society of Cataract ..
09/14 GLAUKOS CORPORATION (NYSE : GKOS) Files An 8-K Regulation FD Disclosure
More news
Sector news : Medical Devices & Implants
11/20DJFISHER & PAYKEL HEALTHCARE : 1st Half Profit Rises
11/13 Poor earnings updates keep European shares at seven-week low
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
11/03 ESSILOR INTERNATIONAL : EU regulators suspend Luxottica, Essilor probe, await da..
More sector news : Medical Devices & Implants
News from SeekingAlpha
11/21 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
11/07 Glaukos' (GKOS) CEO Thomas Burns on Q3 2017 Results - Earnings Call Transcrip..
11/07 Glaukos beats by $0.05, beats on revenue
11/06 Notable earnings after Tuesday?s close
09/21 After Hours Gainers / Losers
Chart GLAUKOS CORP
Duration : Period :
Glaukos Corp Technical Analysis Chart | GKOS | US3773221029 | 4-Traders
Technical analysis trends GLAUKOS CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 43,9 $
Spread / Average Target 73%
EPS Revisions
Managers
NameTitle
Thomas William Burns President, Chief Executive Officer & Director
William J. Link Chairman
Chris M. Calcaterra Chief Operating Officer
Joseph E. Gilliam CFO & Senior VP-Corporate Development
Jeffrey Mark Wells Senior VP-Regulatory, Quality & Clinical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
GLAUKOS CORP-22.89%876
STRYKER CORPORATION29.71%58 280
SMITH & NEPHEW8.68%15 336
WRIGHT MEDICAL GROUP NV7.92%2 520
JAPAN LIFELINE CO., LTD.116.98%2 041
OSSTEM IMPLANT CO LTD--.--%820